Digiliti Money (OTCMKTS: DGLT) and InVitae (NYSE:NVTA) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Earnings & Valuation

This table compares Digiliti Money and InVitae’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Digiliti Money $7.97 million 0.24 -$15.16 million ($6.05) -0.03
InVitae $25.05 million 18.01 -$100.25 million ($2.55) -3.34

Digiliti Money has higher earnings, but lower revenue than InVitae. InVitae is trading at a lower price-to-earnings ratio than Digiliti Money, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Digiliti Money and InVitae, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digiliti Money 0 0 1 0 3.00
InVitae 0 0 3 0 3.00

Digiliti Money presently has a consensus price target of $6.00, suggesting a potential upside of 3,057.89%. InVitae has a consensus price target of $14.33, suggesting a potential upside of 68.23%. Given Digiliti Money’s higher probable upside, research analysts plainly believe Digiliti Money is more favorable than InVitae.


This table compares Digiliti Money and InVitae’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Digiliti Money -147.73% N/A -199.21%
InVitae -206.95% -115.25% -67.79%

Insider and Institutional Ownership

11.3% of Digiliti Money shares are owned by institutional investors. Comparatively, 66.5% of InVitae shares are owned by institutional investors. 50.9% of Digiliti Money shares are owned by insiders. Comparatively, 9.9% of InVitae shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


InVitae beats Digiliti Money on 6 of the 11 factors compared between the two stocks.

Digiliti Money Company Profile

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

InVitae Company Profile

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company’s products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.

Receive News & Ratings for Digiliti Money Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digiliti Money and related companies with MarketBeat.com's FREE daily email newsletter.